L-Ascorbic acid (magnesium)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


L-Ascorbic acid (magnesium)
Description:
L-Ascorbic acid (L-Ascorbate) magnesium, an electron donor, is an endogenous antioxidant. L-Ascorbic acid selectively inhibits Cav3.2 channels with an IC50 of 6.5 μM. L-Ascorbic acid is also a collagen deposition promoter and elastin production inhibitor. L-Ascorbic acid exhibits anticancer effects by generating reactive oxygen species (ROS) and selectively damaging cancer cells[1][2][3][4].Product Name Alternative:
L-Ascorbate (magnesium) ; Vitamin C (magnesium)UNSPSC:
12352200Hazard Statement:
H315-H319-H320Target:
Apoptosis; Calcium Channel; Endogenous Metabolite; Reactive Oxygen Species (ROS)Related Pathways:
Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κBApplications:
Neuroscience-NeurodegenerationField of Research:
Neurological DiseasePurity:
95.0Smiles:
OC ([C@@]1 ([H]) [C@H] (CO) O) =C (O) C (O1) =O.[0.5Mg2+]Molecular Formula:
C6H8O6.1/2MgMolecular Weight:
187.27Precautions:
P264-P280-P302+P352-P305+P351+P338-P362References & Citations:
[1]Sebastian J Padayatty, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003 Feb;22 (1) :18-35. |[2]Michael T Nelson, et al. Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J Neurosci. 2007 Nov 14;27 (46) :12577-83.|[3]Aleksander Hinek, et al. Sodium L-ascorbate enhances elastic fibers deposition by fibroblasts from normal and pathologic human skin. J Dermatol Sci. 2014 Sep;75 (3) :173-82. |[4]Sungrae Cho, et al. Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression. Sci Rep. 2018 Jul 27;8 (1) :11372.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, sealed storage, away from moisture)Scientific Category:
Biochemical Assay ReagentsClinical Information:
No Development ReportedCAS Number:
15431-40-0
